The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Review Article
Medical Progress
PreviousPrevious
Volume 347:1175-1186 October 10, 2002 Number 15
NextNext

Helicobacter pylori Infection
Sebastian Suerbaum, M.D., and Pierre Michetti, M.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Commentary
-Letters

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
Since the first culture of Helicobacter pylori 20 years ago, the diagnosis and treatment of upper gastroduodenal disease have changed dramatically. Peptic ulcer disease is now approached as an infectious disease, in which elimination of the causative agent cures the condition. The role of H. pylori infection in gastric cancers is increasingly recognized, and its role in other diseases of the upper gastrointestinal tract is being evaluated. Enormous progress has been achieved in determining the pathogenesis of this infection. Effective antimicrobial therapy is available, although there is still no ideal treatment, and indications for therapy continue to evolve. This review . . . [Full Text of this Article]

Epidemiology and Transmission

Pathogenesis

Host Response to H. pylori

Clinical Outcomes of Infection

Diagnostic Tests

Treatment of H. pylori Infection

First-Line Therapies

Proton-Pump-Inhibitor–Based Triple Therapies

Ranitidine Bismuth Citrate–Based Therapies

Bismuth-Based Triple Therapies

Second-Line Therapies

Indications for Therapy

Perspective


Source Information

From the Institute of Hygiene and Microbiology, University of Würzburg, Würzburg, Germany (S.S.); and the Division of Gastroenterology and Hepatology, Lausanne University Medical Center, Lausanne, Switzerland (P.M.).

Address reprint requests to Dr. Michetti at the Division of Gastroenterology and Hepatology, BH10N-531, Centre Hospitalier Universitaire Vaudois, CH-1010 Lausanne, Switzerland, or at pierre.michetti@chuv.hospvd.ch.


Related Letters:

Helicobacter pylori
Meyer J. M., Hopkins R. J., Mascitelli L., Pezzetta F.
Extract | Full Text | PDF  
N Engl J Med 2003; 348:363-365, Jan 23, 2003. Correspondence

This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.